The anti-tumor effect of DUSP26 is associated with inhibition of MAPK and Akt signaling pathways that may arise from dephosphorylation of signaling proteins including, p38, STAT1, ERK, YAP, Akt, and AMPK, which are known substrate of DUSP26 enzymatic activity. The gene discussed is STAT1; the disease is neoplasm.